MOMA Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors (NCT06974110) | MOMA Therapeutics | 2025-07-16 |
| Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors (NCT06545942) | MOMA Therapeutics | 2024-08-13 |
Track MOMA Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.